Join Jame as he continues to talks through the ESCMID and IDSA treatment of Multi Drug Resistant Gram negative guidelines/guidance. Callum listens and occasionally asks a question! Jame is so passionate on this subject that we have split the episode into two parts.ECDC guidelines·          https://onlinelibrary.wiley.com/doi/full/10.1111/j.1469-0691.2011.03570.x·          https://www.ecdc.europa.eu/en/news-events/multidrug-resistant-extensively-drug-resistant-and-pandrug-resistant-bacteria-0 Canadian guidelines·          https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/ccdr-volume-44-1-january-4-2018/ccdr-rmtc-44-1-ar07-eng.pdf IDSA-       https://www.idsociety.org/practice-guideline/amr-guidance-2.0/#  Comparison of IDSA and ESCMID-       https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(22)00054-4/fulltext -       https://amr.solutions/2019/01/13/categories-of-resistance-mdr-xdr-pdr-udr-and-new-dtr/